Production (Stage)
CardioComm Solutions, Inc.
EKG.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -5.37% | -45.31% | -48.07% | -55.21% | -26.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.37% | -45.31% | -48.07% | -55.21% | -26.56% |
| Cost of Revenue | -46.11% | -94.44% | -75.00% | -97.76% | -80.06% |
| Gross Profit | 1.83% | -43.36% | -46.94% | -35.01% | 39.59% |
| SG&A Expenses | -33.48% | -30.71% | -7.70% | 2.47% | 76.07% |
| Depreciation & Amortization | 43.59% | 23.81% | 13.33% | -5.45% | -38.10% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -33.20% | -31.86% | -9.62% | -27.62% | -0.87% |
| Operating Income | 80.56% | -472.00% | -768.12% | -310.76% | -144.66% |
| Income Before Tax | -3.76% | -154.71% | -2,065.38% | 188.03% | -50.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.76% | -154.71% | -2,065.38% | 188.03% | -50.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.76% | -154.71% | -2,065.38% | 188.03% | -50.12% |
| EBIT | 80.56% | -472.00% | -768.12% | -310.76% | -144.66% |
| EBITDA | 81.78% | -555.81% | -908.47% | -370.80% | -151.51% |
| EPS Basic | 25.00% | -200.00% | -- | 100.00% | -33.33% |
| Normalized Basic EPS | 33.33% | -100.00% | -- | -- | -50.00% |
| EPS Diluted | 25.00% | -200.00% | -- | 100.00% | -33.33% |
| Normalized Diluted EPS | 33.33% | -100.00% | -- | -- | -50.00% |
| Average Basic Shares Outstanding | 27.80% | 25.01% | 0.00% | 0.10% | 0.16% |
| Average Diluted Shares Outstanding | 27.80% | 25.01% | 0.00% | 0.10% | 0.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |